High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696 (Q73567640)
Jump to navigation
Jump to search
scientific article published on 01 March 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696 |
scientific article published on 01 March 2001 |
Statements
High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696 (English)
J M Kirkwood
J Ibrahim
D H Lawson
M B Atkins
S S Agarwala
K Collins
R Mascari
D M Morrissey